Malaria Chemoprophylaxis: Strategies for Risk Groups

Patricia Schlagenhauf(World Health Organization - Pakistan), Eskild Petersen(Roskilde University)
Clinical Microbiology Reviews
July 1, 2008
10.1128/cmr.00059-07
Cited by 107

Related Papers

Covid-19 and community mitigation strategies in a pandemic
|BMJ|2020|584
Going global – Travel and the 2019 novel coronavirus
|Travel Medicine and Infectious Disease|2020|376
Chikungunya and dengue autochthonous cases in Europe, 2007–2012
|Travel Medicine and Infectious Disease|2013|255
Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation
|The Lancet Infectious Diseases|2014|248
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
|BMJ|2003|243